Targeting NLRP3 signaling reduces myocarditis-induced arrhythmogenesis and cardiac remodeling

Chye-Gen Chin1,2, Yao-Chang Chen3, Fong-Jhih Lin1,3

  • 1Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, 250 Wu-Hsing Street, Taipei, 11031, Taiwan.

PubMed
Abstract

Insights

Myocarditis increases ventricular arrhythmia risk, particularly from the right ventricular outflow tract (RVOT). Inhibiting NLRP3 signaling with MCC950 may mitigate these effects by reducing inflammation and abnormal electrical activity.

Area of Science:

  • Cardiology
  • Immunology
  • Electrophysiology

Background:

  • Myocarditis significantly elevates the risk of ventricular arrhythmia, with approximately 30% originating from the right ventricular outflow tract (RVOT).
  • The specific role of NLRP3 inflammasome signaling in RVOT arrhythmogenesis remains largely unexplored.

Purpose of the Study:

  • To investigate the role of NLRP3 inflammasome signaling in myocarditis-induced RVOT arrhythmogenesis.
  • To evaluate the therapeutic potential of NLRP3 inhibition in mitigating RVOT arrhythmias.

Main Methods:

  • Myocarditis was induced in rats using myosin peptides; experimental groups received the NLRP3 inhibitor MCC950.
  • Cardiac function was assessed via electrocardiography and echocardiography.
  • RVOT, RVA, and LV tissues underwent histopathological analysis, microelectrode recordings, and myocyte-level investigations (patch-clamp, Ca2+ transients, protein expression).

Main Results:

  • Myocarditis led to reduced LV ejection fraction and increased premature ventricular contractions, with heightened NLRP3 expression and inflammation in RVOT/RVA.
  • MCC950 treatment improved cardiac function and reduced arrhythmias.
  • RVOT myocytes from myocarditis rats showed altered ionic currents, impaired Ca2+ handling, elevated reactive oxygen species, and increased Ca2+/calmodulin-dependent protein kinase II, which were reversed by MCC950.

Conclusions:

  • Myocarditis induces electrical and structural remodeling in the RVOT, promoting arrhythmogenesis.
  • Inhibition of NLRP3 signaling presents a potential therapeutic strategy to manage RVOT arrhythmias associated with myocarditis.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...